Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action "antiviral-antiinflammatory" drugs against COVID-19. - Amgad M. Rabie; Meriem Khedraoui; Samir Chtita (Comput. Biol. Chem., 2025)